BeneFIX 250unit powder and solvent for solution for infusion vials

国: イギリス

言語: 英語

ソース: MHRA (Medicines & Healthcare Products Regulatory Agency)

有効成分:

Nonacog alfa

から入手可能:

Pfizer Ltd

ATCコード:

B02BD04

INN（国際名）:

Nonacog alfa

投薬量:

250unit

医薬品形態:

Powder and solvent for solution for infusion

投与経路:

Intravenous

クラス:

No Controlled Drug Status

処方タイプ:

Valid as a prescribable product

製品概要:

BNF: 02110000; GTIN: 5013457021851

情報リーフレット

Page 1 of 10
PACKAGE LEAFLET: INFORMATION FOR THE USER
BENEFIX 250 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
BENEFIX 500 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
BENEFIX 1000 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
BENEFIX 1500 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
BENEFIX 2000 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
BENEFIX 3000 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
Nonacog alfa (recombinant coagulation factor IX)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects talk to your doctor, pharmacist or nurse.
This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What BeneFIX is and what it is used for
2.
What you need to know before you take BeneFIX
3.
How to take BeneFIX
4.
Possible side effects
5.
How to store BeneFIX
6.
Contents of the pack and other information
1. WHAT BENEFIX IS AND WHAT IT IS USED FOR
BeneFIX is an injectable clotting (coagulation) factor IX product that
is produced by recombinant
DNA technology. The active ingredient in BeneFIX is nonacog alfa.
People who are born with
haemophilia B (Christmas disease) lack sufficient factor IX to control
bleeding. BeneFIX works by
replacing factor IX in haemophilia B patients to enable their blood to
clot.
BeneFIX is used for the treatment and prevention of bleeding in
patients with haemophilia B
(congenital factor IX deficiency) in all age groups.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE BENEFIX
DO NOT TAKE BENEFIX:
-
If you are allergic to nonacog alfa or any of the other ingredients of
this medicine (listed in
section 6).
-
If you are allergic to hamster proteins. WARNINGS

製品の特徴

OBJECT 1
BENEFIX
Summary of Product Characteristics Updated 10-Jul-2017 | Pfizer
Limited
1. Name of the medicinal product
BeneFIX 250 IU powder and solvent for solution for injection
BeneFIX 500 IU powder and solvent for solution for injection
BeneFIX 1000 IU powder and solvent for solution for injection
BeneFIX 1500 IU powder and solvent for solution for injection
BeneFIX 2000 IU powder and solvent for solution for injection
BeneFIX 3000 IU powder and solvent for solution for injection
2. Qualitative and quantitative composition
BeneFIX 250 IU powder and solvent for solution for injection
Each vial contains nominally 250 IU nonacog alfa (recombinant
coagulation factor IX). After
reconstitution with the accompanying 5 mL (0.234%) sodium chloride
solution for injection, each mL of
the solution contains approximately 50 IU nonacog alfa.
BeneFIX 500 IU powder and solvent for solution for injection
Each vial contains nominally 500 IU nonacog alfa (recombinant
coagulation factor IX). After
reconstitution with the accompanying 5 mL (0.234%) sodium chloride
solution for injection, each mL of
the solution contains approximately 100 IU nonacog alfa.
BeneFIX 1000 IU powder and solvent for solution for injection
Each vial contains nominally 1000 IU nonacog alfa (recombinant
coagulation factor IX). After
reconstitution with the accompanying 5 mL (0.234%) sodium chloride
solution for injection, each mL of
the solution contains approximately 200 IU nonacog alfa.
BeneFIX 1500 IU powder and solvent for solution for injection
Each vial contains nominally 1500 IU nonacog alfa (recombinant
coagulation factor IX). After
reconstitution with the accompanying 5 mL (0.234%) sodium chloride
solution for injection, each mL of
the solution contains approximately 300 IU nonacog alfa.
BeneFIX 2000 IU powder and solvent for solution for injection
Each vial contains nominally 2000 IU nonacog alfa (recombinant
coagulation factor IX). After
reconstitution with the accompanying 5 mL (0.234%) sodium chloride
solution for injection, each mL of
the